Choice of Drug for Malaria Prevention During Pregnancy Does Not Affect Infant Serologic Responses to Plasmodium falciparum Erythrocyte Membrane Proteins 1
Open Forum Infectious Diseases · 31.01.2025 · 12 (2)
DOI: 10.1093/ofid/ofaf037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 23.01.2025. Verfasst von Amed Ouattara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Research Program, Center for Vaccine Development and Global Heath, School of Medicine, University of Maryland, Baltimore, Maryland, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
While sulfadoxine-pyrimethamine has been the primary drug in intermittent preventive treatment in pregnancy, dihydroartemisinin-piperaquine (DP) is being considered as an alternative. DP may lead to lower antimalarial antibodies in the mother, resulting in higher risk of malaria in infancy. We probed cord blood sera collected from women enrolled in a clinical trial of sulfadoxine-pyrimethamine vs DP on a protein microarray containing diverse Plasmodium falciparum erythrocyte membrane proteins 1 to measure the impact of intermittent preventive treatment in pregnancy on proteins associated with malaria disease susceptibility. These results suggest that effective maternal malaria prevention may not alter the susceptibility of infants to malaria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Malaria Research Program, Center for Vaccine Development and Global Heath, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
- Vaccine Research and Development Center, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.
- Malaria Alert Center, Kamuzu University of Health Sciences, Blantyre, Malawi.
ORCID-Profile: Amed Ouattara, Rie Nakajima, Aarti Jain, Miriam K Laufer
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- National Institutes of Health
- NIH Fund
Zitieren
APA
Ouattara, A., Andronescu, L. R., Adams, M., Sharma, A., Nakajima, R., Jain, A., Taghavian, O., Jasinskas, A., Felgner, P. L., Mathanga, D. P., Chinkhumba, J., Laufer, M. K., & Travassos, M. A. (2025). Choice of Drug for Malaria Prevention During Pregnancy Does Not Affect Infant Serologic Responses to Plasmodium falciparum Erythrocyte Membrane Proteins 1. Open Forum Infectious Diseases, 12(2). https://doi.org/10.1093/ofid/ofaf037
Vancouver
Ouattara A, Andronescu LR, Adams M, Sharma A, Nakajima R, Jain A, et al. Choice of Drug for Malaria Prevention During Pregnancy Does Not Affect Infant Serologic Responses to Plasmodium falciparum Erythrocyte Membrane Proteins 1. Open Forum Infectious Diseases. 2025;12(2). doi:10.1093/ofid/ofaf037
BibTeX
@article{Ouattara2025,
author = {Ouattara, Amed and Andronescu, Liana R and Adams, Matthew and Sharma, Ankur and Nakajima, Rie and Jain, Aarti and Taghavian, Omid and Jasinskas, Algis and Felgner, Philip L and Mathanga, Don P and Chinkhumba, Jobiba and Laufer, Miriam K and Travassos, Mark A},
title = {Choice of Drug for Malaria Prevention During Pregnancy Does Not Affect Infant Serologic Responses to Plasmodium falciparum Erythrocyte Membrane Proteins 1},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {2},
doi = {10.1093/ofid/ofaf037}
}
EUVIMED